GlobeNewsWire
02 Jun 2026, 20:49 UTC · 16w ago
Verdict
Headline takes no side. We score TLSI −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
TriSalus Life Sciences (TLSI) cut its full-year revenue guidance to $54 million–$57 million, a $5.5 million reduction from previous targets.
More negative than 95% of claims this week
FDA clearance for TriNav Advance is delayed by approximately five months past the 30-day MDUFA review goal.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 90% of claims this week
Pomerantz LLP is investigating TriSalus Life Sciences for potential securities fraud or unlawful business practices.
More negative than 85% of claims this week
TriSalus reported Q1 2026 revenue of $8.90 million, representing a 2.92% year-over-year decline.
So whatA slight decline in quarterly revenue confirms a trend of slowing growth but is less impactful than the full-year guidance cut.
More negative than 69% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities fraud investigation, revenue declines, lowered guidance, and a significant stock price drop.
More negative than 73% of ticker scores this week
The company is the subject of a legal investigation by Pomerantz LLP on behalf of investors.
More negative than 73% of ticker scores this week
The company is the subject of a legal investigation by Pomerantz LLP on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
3h ago
+31.4%
Price is moving against the score
$4.39 vs $3.34 close before publication (Jun 2) · not market-adjusted
TLSI chart →
